The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cytokine

• Publication date

  2015-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cyto.2014.10.025PMID 25461393
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atypical femoral fractures: retrospective radiological study of 319 femoral fractures and presentation of clinical cases

  2014cited by this paper
• Osteocyte-induced angiogenesis via VEGF–MAPK-dependent pathways in endothelial cells

  2013cited by this paper
• There are many potential medical therapies for atraumatic osteonecrosis.

  2013cited by this paper
• Zoledronic acid acutely increases sclerostin serum levels in women with postmenopausal osteoporosis.

  2013cited by this paper
• The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells.

  2012cited by this paper
• Bisphosphonates: effects on osteoblast

  2012cited by this paper
• Effects of alendronate on human osteoblast-like MG63 cells and matrix metalloproteinases.

  2012cited by this paper
• Clinical role of bisphosphonate therapy

  2012cited by this paper
• Osteomalacia: the missing link in the pathogenesis of bisphosphonate-related osteonecrosis of the jaws?

  2012cited by this paper
• Role of angiogenesis on bone formation.

  2012cited by this paper
• Vitamin D improves the angiogenic properties of endothelial progenitor cells.

  2012cited by this paper
• Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw

  2011cited by this paper
• Dose-dependent differential effects of risedronate on gene expression in osteoblasts.

  2011cited by this paper
• Bisphosphonate‐related osteonecrosis of the jaw: an overview

  2011cited by this paper
• Anatomic site variability in rat skeletal uptake and desorption of fluorescently labeled bisphosphonate.

  2011cited by this paper
• Differential impairment of vascularization and angiogenesis in bisphosphonate-associated osteonecrosis of the jaw-related mucoperiosteal tissue.

  2011cited by this paper
• Anti‐tumour and anti‐angiogenetic effects of zoledronic acid on human non‐small‐cell lung cancer cell line

  2011cited by this paper
• Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.

  2011cited by this paper
• Metronomic administration of Zoledronic Acid and Taxotere combination in castration resistant prostate cancer patients: Phase I ZANTE trial

  2010cited by this paper
• Atypical femoral fractures and bisphosphonate use.

  2010cited by this paper
• Zoledronic acid: an unending tale for an antiresorptive agent

  2010cited by this paper
• Bisphosphonates suppress insulin‐like growth factor 1‐induced angiogenesis via the HIF‐1α/VEGF signaling pathways in human breast cancer cells

  2010cited by this paper
• Concise Review: Insights from Normal Bone Remodeling and Stem Cell‐Based Therapies for Bone Repair

  2010cited by this paper
• Increased Prevalence of Bisphosphonate-Related Osteonecrosis of the Jaw with Vitamin D Deficiency in Rats

  2010cited by this paper
• Cutting the limits of aminobisphosphonates: new strategies for the potentiation of their anti-tumour effects.

  2009cited by this paper
• Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?

  2009cited by this paper
• Osteonecrosis of the jaw: who gets it, and why?

  2009cited by this paper
• Vascular endothelial growth factor regulates osteoblast survival – evidence for an autocrine feedback mechanism

  2009cited by this paper
• 1,25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter.

  2009cited by this paper
• Wnt/Frizzled signaling in angiogenesis

  2008cited by this paper
• Aminobisphosphonates Cause Osteoblast Apoptosis and Inhibit Bone Nodule Formation In Vitro

  2008cited by this paper
• Antitumoral and antiangiogenic efficacy of bisphosphonates in vitro and in a murine RENCA model.

  2008cited by this paper
• A physical mechanism for coupling bone resorption and formation in adult human bone.

  2008cited by this paper
• Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

  2007cited by this paper
• Osteoblast-specific Angiopoietin 1 overexpression increases bone mass.

  2007cited by this paper
• ESE-1 Is a Novel Transcriptional Mediator of Angiopoietin-1 Expression in the Setting of Inflammation*

  2004cited by this paper
• Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro.

  2003cited by this paper
• Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients.

  2003cited by this paper
• RANKL and Vascular Endothelial Growth Factor (VEGF) Induce Osteoclast Chemotaxis through an ERK1/2-dependent Mechanism*

  2003cited by this paper
• Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics.

  2002cited by this paper
• Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone.

  2001cited by this paper
• Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.

  2001cited by this paper
• The angiogenic response to skeletal injury is preserved in the elderly

  2001cited by this paper
• Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers

  2001cited by this paper
• VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism.

  2000cited by this paper
• Cellular and molecular mechanisms of action of bisphosphonates

  2000cited by this paper
• Transforming growth factor-β1 modulates the expression of vascular endothelial growth factor by osteoblasts.

  1999cited by this paper
• Nitrogen‐Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post‐Translational Prenylation of GTP‐Binding Proteins, Including Ras

  1998cited by this paper
• Signaling Vascular Morphogenesis and Maintenance

  1997cited by this paper
• Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

  1991cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Molecular Basis of Surfactin-Induced Macrophage Modulation and Its Implications in Medication-Related Osteonecrosis of the Jaw Pathogenesis

  2026cites this paper
• Osteoblastic cell responses to zoledronate treatment in-vitro: A systematic review.

  2026cites this paper
• The role of amino bisphosphonates zoledronate and alendronate in shaping immunomodulatory profile and angiogenic potential of human periodontal ligament stem cells

  2025cites this paper
• Enamel matrix derivative in the prevention and treatment of medication-related osteonecrosis of the jaws in rats.

  2025cites this paper
• A Systematic Review of the Effects of Bisphosphonates on Osteoblasts In Vitro

  2025influential citation
• Nitrogen-Containing Bisphosphonate Carbon Dots with High Affinity to Calcium-Based Biomaterials for Suppression of Osteoclasts

  2025cites this paper
• Could MRONJ Be Related to Osimertinib Monotherapy in Lung Cancer Patients after Denosumab Suspension?

  2024cites this paper
• Role of bisphosphonates in hypertrophic osteoarthropathy: a systematic review

  2024cites this paper
• Mining and analysis of adverse event signals for alendronate based on the real-world data of FDA adverse event reporting system database

  2024cites this paper
• Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis

  2024cites this paper
• Amelioration of breast cancer therapies through normalization of tumor vessels and microenvironment: paradigm shift to improve drug perfusion and nanocarrier permeation

  2024cites this paper
• Medication-related osteonecrosis of the jaw (MRONJ) systemic review: mevalonate pathway mechanisms explored.

  2024cites this paper
• Pathogenesis of Medication-Related Osteonecrosis of the Jaw: Odontogenic Infection-Preceding Type and Osteonecrosis-Preceding Type

  2024cites this paper
• Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw?

  2023cites this paper
• Are secondary effects of bisphosphonates on the vascular system of bone contributing to increased risk for atypical femoral fractures in osteoporosis?

  2023cites this paper
• Influence of antiresorptive/antiangiogenic therapy on changes in periodontal and oral tissue structures: a histomorphometrical analysis in rats

  2023cites this paper
• Influence of antiresorptive/antiangiogenic therapy on the surgical treatment outcomes of experimentally induced peri-implantitis lesions

  2023cites this paper
• Resveratrol for preventing medication-related osteonecrosis of the jaws in rats.

  2023cites this paper
• Effects of ranibizumab and zoledronic acid on endometriosis in a rat model

  2022cites this paper
• American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaw-2022 Update.

  2022cites this paper
• Expression of angiogenic markers in jawbones and femur in a rat model treated with zoledronic acid

  2022cites this paper
• Medication-Related Osteonecrosis of the Jaw: 14 Years’ Retrospective Study on Pathogenetic Trigger Events

  2022cites this paper
• Vascular response to stress: Protective action of the bisphosphonate alendronate

  2022cites this paper
• Targeting a therapeutically relevant concentration of alendronate for in vitro studies on osteoblasts

  2022cites this paper
• Medication-Related Osteonecrosis of the Jaw – 2022 Update

  2022cites this paper
• Machine Learning Approaches for Predicting Bisphosphonate-Related Osteonecrosis in Women with Osteoporosis Using VEGFA Gene Polymorphisms

  2021cites this paper
• Sustained delivery of growth factors and alendronate using partially demineralized dentin matrix for endogenous periodontal regeneration

  2021cites this paper
• Lipopolysaccharide and High Concentrations of Glucose Enhances Zoledronate-induced Increase in RANKL/OPG Ratio by Upregulating PGE2 Production in Osteoblasts

  2021cites this paper
• Effects of ranibizumab and zoledronic acid on endometriosis in a rat model

  2021cites this paper
• Zoledronic Acid Induces Early Changes of VEGF Levels in Women With Postmenopausal Osteoporosis

  2021cites this paper
• Alendronate-induced Perturbation of the Bone Proteome and Microenvironmental Pathophysiology

  2021cites this paper
• Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D

  2021influential citation
• Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw

  2020cites this paper
• Liposome-Encapsulated Zoledronate Favors Tumor Vascular Normalization and Enhances Anticancer Efficacy of Cisplatin

  2020cites this paper
• The effect of etidronate on choroidal neovascular activity in patients with pseudoxanthoma elasticum

  2020cites this paper
• A new anabolic compound, LLP2A-Ale, reserves periodontal bone loss in mice through augmentation of bone formation

  2020cites this paper
• Alendronate enhances osseointegration in a murine implant model

  2020cites this paper
• Awareness among patient at risk of developing Medication Related Osteonecrosis of the Jaw (MRONJ) – A primary prevention strategy

  2020cites this paper
• Liposome-Encapsulated Zoledronate Favors Tumor Vascular Normalization and Enhances Anticancer Efficacy of Cisplatin

  2020cites this paper
• Does bisphosphonate treatment reduce the risk of future cancer?

  2019cites this paper
• Genetically Decreased Circulating Vascular Endothelial Growth Factor and Osteoporosis Outcomes: A Mendelian Randomization Study

  2019cites this paper
• Identification of molecular markers for pre-thrombotic state: validation in the rabbits with tibia fracture or lung cancer

  2019cites this paper
• Vasculature submucosal changes at early stages of osteonecrosis of the jaw (ONJ).

  2019cites this paper
• Statins: A Conceivable Remedial Role for the Regulation of Cancer Progression

  2019cites this paper
• Histatin-1 counteracts the cytotoxic and antimigratory effects of zoledronic acid in endothelial and osteoblast-like cells.

  2019cites this paper
• Effect of Alendronic Acid on Buccal Mucosa

  2018cites this paper
• The effects of icariin on wound healing of extraction sites with administration of zoledronic and dexamethasone: A rat model study

  2018cites this paper
• Cytoprotective effect of flavonoid‐induced autophagy on bisphosphonate mediated cell death in osteoblast

  2018influential citation
• Adaptable Hydrogels Mediate Cofactor‐Assisted Activation of Biomarker‐Responsive Drug Delivery via Positive Feedback for Enhanced Tissue Regeneration

  2018cites this paper
• Oral Mucosal Ulceration Induced by Alendronic Acid: A Case Series

  2018cites this paper
• Paradoxical side effects of bisphosphonates on the skeleton: What do we know and what can we do?

  2018cites this paper
• Cytotoxic and inflammatory effects of alendronate and zolendronate on human osteoblasts, gingival fibroblasts and osteosarcoma cells.

  2018cites this paper
• Bisphosphonate Modulation of the Gene Expression of Different Markers Involved in Osteoblast Physiology: Possible Implications in Bisphosphonate-Related Osteonecrosis of the Jaw

  2018cites this paper
• A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma

  2017cites this paper
• Angiogenesis in the Development of Medication-Related Osteonecrosis of the Jaws: An Overview

  2016cites this paper
• Bactericidal efficacy of cold plasma in processed bone. A new approach for adjuvant therapy of medication-related osteonecrosis of the jaw?

  2016cites this paper
• Fraturas de insuficiência do fémur em doentes sob terapêutica prolongada com bifosfonatos

  2016cites this paper
• Atypical femoral fractures and current management

  2016cites this paper
• Adverse cardiovascular effects of nitrogen-containing bisphosphonates in patients with osteoporosis: A nationwide population-based retrospective study.

  2016cites this paper
• TITLE: Reciprocal Interactions between Multiple Myeloma Cells and Osteoprogenitor Cells Affect Bone Formation and Tumor Growth”

  2015cites this paper
• Dynamic interplay between bone and multiple myeloma: emerging roles of the osteoblast.

  2015cites this paper
• In�uence of antiresorptive/antiangiogenic therapy on changes in periodontal and oral tissue structures: a histomorphometrical analysis in rats

  year unknowncites this paper